Genesis Healthcare Inc (GEN) COO Paul David Bach Sells 5,735 Shares of Stock

Share on StockTwits

Genesis Healthcare Inc (NYSE:GEN) COO Paul David Bach sold 5,735 shares of the firm’s stock in a transaction dated Tuesday, June 12th. The stock was sold at an average price of $2.28, for a total transaction of $13,075.80. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

Paul David Bach also recently made the following trade(s):

  • On Tuesday, June 5th, Paul David Bach sold 10,131 shares of Genesis Healthcare stock. The stock was sold at an average price of $2.19, for a total transaction of $22,186.89.

Shares of Genesis Healthcare traded up $0.25, hitting $2.65, during midday trading on Thursday, MarketBeat.com reports. The company’s stock had a trading volume of 1,813,857 shares, compared to its average volume of 714,116. Genesis Healthcare Inc has a 12-month low of $0.60 and a 12-month high of $2.70. The company has a market cap of $366.72 million, a P/E ratio of -1.27 and a beta of 1.00. The company has a current ratio of 1.11, a quick ratio of 1.11 and a debt-to-equity ratio of -2.80.

Genesis Healthcare (NYSE:GEN) last released its quarterly earnings data on Thursday, May 10th. The company reported ($0.70) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.36) by ($0.34). The company had revenue of $1.30 billion for the quarter, compared to analysts’ expectations of $1.32 billion. During the same period in the prior year, the firm posted ($0.55) EPS. analysts expect that Genesis Healthcare Inc will post -1.32 earnings per share for the current year.

A number of institutional investors have recently added to or reduced their stakes in GEN. Schwab Charles Investment Management Inc. acquired a new stake in Genesis Healthcare during the first quarter worth about $153,000. BSW Wealth Partners increased its position in Genesis Healthcare by 74.2% during the first quarter. BSW Wealth Partners now owns 115,000 shares of the company’s stock worth $174,000 after purchasing an additional 49,000 shares during the last quarter. Millennium Management LLC acquired a new stake in Genesis Healthcare during the fourth quarter worth about $184,000. Virtu Financial LLC acquired a new stake in Genesis Healthcare during the fourth quarter worth about $203,000. Finally, California Public Employees Retirement System increased its position in Genesis Healthcare by 23.3% during the first quarter. California Public Employees Retirement System now owns 309,910 shares of the company’s stock worth $468,000 after purchasing an additional 58,610 shares during the last quarter. Hedge funds and other institutional investors own 18.70% of the company’s stock.

Several equities analysts have recently weighed in on the stock. Stephens reissued a “hold” rating and issued a $2.00 price target on shares of Genesis Healthcare in a research note on Monday, March 19th. Stifel Nicolaus set a $2.00 price target on shares of Genesis Healthcare and gave the stock a “hold” rating in a research note on Tuesday, April 24th. Finally, ValuEngine downgraded shares of Genesis Healthcare from a “buy” rating to a “hold” rating in a research note on Monday, April 2nd. Four analysts have rated the stock with a hold rating and one has given a buy rating to the stock. Genesis Healthcare presently has an average rating of “Hold” and a consensus target price of $2.00.

About Genesis Healthcare

Genesis Healthcare, Inc, together with its subsidiaries, owns and operates skilled nursing facilities and assisted/senior living facilities in the United States. The company operates through three segments: Inpatient Services, Rehabilitation Therapy Services, and All Other Services. It also provides a range of rehabilitation therapy services, including speech-language pathology, physical therapy, occupational therapy, and respiratory therapy.

Insider Buying and Selling by Quarter for Genesis Healthcare (NYSE:GEN)

Receive News & Ratings for Genesis Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genesis Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Axiom Price Reaches $0.0078 on Exchanges
Axiom Price Reaches $0.0078 on Exchanges
Starta Hits 24-Hour Trading Volume of $0.00
Starta Hits 24-Hour Trading Volume of $0.00
Zacks: Brokerages Expect MTS Systems Co.  Will Announce Earnings of $0.63 Per Share
Zacks: Brokerages Expect MTS Systems Co. Will Announce Earnings of $0.63 Per Share
Obalon Therapeutics  Getting Somewhat Positive Media Coverage, Study Shows
Obalon Therapeutics Getting Somewhat Positive Media Coverage, Study Shows
Novus Therapeutics  Receives News Impact Score of 0.16
Novus Therapeutics Receives News Impact Score of 0.16
$4.68 Earnings Per Share Expected for Regeneron Pharmaceuticals Inc  This Quarter
$4.68 Earnings Per Share Expected for Regeneron Pharmaceuticals Inc This Quarter


Leave a Reply

 
© 2006-2018 Zolmax.